» Articles » PMID: 21903297

Clinical Presentation of Dengue Among Patients Admitted to the Adult Emergency Department of a Tertiary Care Hospital in Martinique: Implications for Triage, Management, and Reporting

Overview
Journal Ann Emerg Med
Specialty Emergency Medicine
Date 2011 Sep 10
PMID 21903297
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objective: During dengue epidemics, emergency physicians face large numbers of patients with acute febrile illness. Triage algorithms and appropriate reporting systems are useful to manage patients and prioritize resources. We identify possible adaptations to these systems to improve the management of patients during epidemics.

Methods: In a prospective observational study in the adult emergency department (ED) of a tertiary care hospital, we enrolled all patients with febrile illness and a confirmed diagnosis of dengue (ribonucleic acid identification). We then retrospectively classified cases according to the initial clinical presentation at the ED.

Results: We enrolled 715 patients (332 male patients), aged 14 to 91 years (median 35 years). Severe illness was documented in 332 cases (46.4%) and was mostly caused by serotype 2, or a secondary infection of any serotype. Severe forms included dengue hemorrhagic fever or dengue shock syndrome (104/332; 31.3%), severe bleeding (9/332; 2.7%), and acute organ failure (56/332; 16.9%). The other patients with severe illness (171/332; 51.5%) presented with symptoms of presyncope, intense weakness, prolonged gastrointestinal symptoms, and hypotension. This presentation was common during epidemics and appeared to be associated with dehydration and electrolyte loss that improved markedly within 24 hours with saline solution infusion. This group did not have evidence of plasma leakage, although similar features were observed in patients with dengue hemorrhagic fever/dengue shock syndrome.

Conclusion: Dengue has a wide range of clinical presentations in the ED. Many patients who appear seriously ill on presentation will respond to intravenous fluids.

Citing Articles

Dengue severity by serotype and immune status in 19 years of pediatric clinical studies in Nicaragua.

Narvaez F, Montenegro C, Juarez J, Zambrana J, Gonzalez K, Videa E PLoS Negl Trop Dis. 2025; 19(1):e0012811.

PMID: 39792951 PMC: 11750095. DOI: 10.1371/journal.pntd.0012811.


Plasma leakage in dengue: a systematic review of prospective observational studies.

Rodrigo C, Sigera C, Fernando D, Rajapakse S BMC Infect Dis. 2021; 21(1):1082.

PMID: 34670495 PMC: 8527656. DOI: 10.1186/s12879-021-06793-2.


Characterization of clinical patterns of dengue patients using an unsupervised machine learning approach.

Hair G, Nobre F, Brasil P BMC Infect Dis. 2019; 19(1):649.

PMID: 31331271 PMC: 6647280. DOI: 10.1186/s12879-019-4282-y.


Development of standard clinical endpoints for use in dengue interventional trials.

Tomashek K, Wills B, Lum L, Thomas L, Durbin A, Leo Y PLoS Negl Trop Dis. 2018; 12(10):e0006497.

PMID: 30286085 PMC: 6171842. DOI: 10.1371/journal.pntd.0006497.


Dengue Virus Serotypes 1 and 2 Responsible for Major Dengue Outbreaks in Nepal: Clinical, Laboratory, and Epidemiological Features.

Dumre S, Bhandari R, Shakya G, Shrestha S, Cherif M, Ghimire P Am J Trop Med Hyg. 2017; 97(4):1062-1069.

PMID: 29031282 PMC: 5637613. DOI: 10.4269/ajtmh.17-0221.